Skip to main content
Premium Trial:

Request an Annual Quote

UW-Madison Opens Public-Private Institute

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Two new institutes aimed at bringing together public and private research efforts in epigenetics, personalized medicine, systems biology, and other areas opened Thursday on the campus of the University of Wisconsin-Madison.

The 300,000-square-foot Wisconsin Institutes for Discovery building in Madison houses the UW-Madison Wisconsin Institute for Discovery and the private Morgridge Institute for Research.

The costs of the project, which totaled $150 million and included $60 million for laboratories, equipment and support, was funded by UW-Madison, the State of Wisconsin, private donors John and Tashia Morgridge, and the Wisconsin Alumni Research Foundation.

Researchers at the Wisconsin Institute for Discovery will engage in studies focused on epigenetics, personalized diagnostic and therapeutic technologies, systems biology research, and tissue engineering studies, among others.

The Morgridge Institute for Research will serve as home for studies of virology, development of new medical devices, pharmaceutical informatics, and regenerative biology.

Support services for both institutes, which could employ up to 350 people, will include core computational technologies and education research efforts focused on helping the public learn more about science and biomedical and health management concepts.

"The institutes were created to make the UW-Madison even more competitive than it is," WARF's Managing Director Carl Gulbrandsen said in a statement. "Putting a private research institute next to a public research institute allows the public side to leverage the flexibility and nimbleness of the private side and the private side to take advantage of the impressive infrastructure and human capital available at UW-Madison."

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.